Celltrion, Inc is a biopharmaceutical company. The company is a leader in biotechnology research and is the largest manufacturer and exporter of biosimilars in Korea, with a production capacity of 250,000L. The company is involved in the development of Live Biotherapeutic Products (LPBs) and various platform technologies such as subcutaneous formulation, ADC, multispecific antibodies, and mRNA. Celltrion provides integrated one-stop solutions for R&D, clinical trials, government approvals, production, and distribution. The company's biopharmaceuticals reach patients in over 100 countries and have secured regulatory approvals for multiple antibody products in over 100 countries. Celltrion is focused on developing new biologics and drug delivery platforms.
Headquarters
13-6 Songdo-Dong, Yeonsu-Gu
Incheon; Incheon;
Postal Code: 406-840
Contact Details: Purchase the Celltrion Co.,Ltd. report to view the information.
Website: http://www.celltrion.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service